Back to Search
DR. RICHARD ANTHONY AMATO M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1366423840IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
036082233(IL)ME64512(FL)35.067430(OH)
Education
CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1980
Research & Publications (20)
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.
PMID 19306412·Cancer·2009
3-trial
Improving genetic health care: a Northern New England pilot project addressing the genetic evaluation of the child with developmental delays or intellectual disability.
PMID 19621460·Am J Med Genet C Semin Med Genet·2009
4-observational
Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trial.
PMID 19561532·J Immunother·2009
3-trial
Radiosensitization by inhibiting STAT1 in renal cell carcinoma.
PMID 19100922·Int J Radiat Oncol Biol Phys·2009
8-other
Relative resistance of SGK1 knockout mice against chemical carcinogenesis.
PMID 19548318·IUBMB Life·2009
7-preclinical
Ventilator-associated pneumonia in the pediatric intensive care unit: characterizing the problem and implementing a sustainable solution.
PMID 19054530·J Pediatr·2009
3-trial
Case 6/2008: a 54 year-old male with hemiparesy and seizures since childhood evolving with heart failure 10 years after precordial pain and normal coronary angiography.
PMID 19142367·Arq Bras Cardiol·2008
5-case
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.
PMID 18661519·Int J Cancer·2008
8-other
Interferon-alpha plus capecitabine and thalidomide in patients with metastatic renal cell cancer.
PMID 18472641·J Exp Ther Oncol·2008
3-trial
Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.
PMID 18483093·J Nucl Med·2008
4-observational
Vaccination of renal cell cancer patients with modified vaccinia ankara delivering tumor antigen 5T4 (TroVax) administered with interleukin 2: a phase II trial.
PMID 19010868·Clin Cancer Res·2008
3-trial
Stereotactic body radiotherapy in the management of painful bone metastases.
PMID 18619121·Oncology (Williston Park)·2008
6-review
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.
PMID 18573906·J Exp Med·2008
3-trial
Pilot study of rapamycin in patients with hormone-refractory prostate cancer.
PMID 18824432·Clin Genitourin Cancer·2008
8-other
Interferon-alpha in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial.
PMID 18418219·Anticancer Drugs·2008
3-trial
Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results.
PMID 18824428·Clin Genitourin Cancer·2008
3-trial
A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma.
PMID 17701037·Cancer Chemother Pharmacol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 8401 MARKET ST
BOARDMAN, OH 44512 - Phone
- (330) 729-2729
Quick Facts
- NPI
- 1366423840
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile